- Perdoceo (link)
- Market cap: 817M
- EV = 341M
- Enterprise multiple = 3 ~ 4.1
- Positive and growing operating cash flow from 2018~2020
- No dividend
- Small buyback amount compared with cash/short-term investment held
- "Regulatory requirements and extensive interpretation" from new government is the major business risk.
- Insiders keep selling at 11~13 is a big warning. Total amount of shares held by insiders is less than 1% which means interests are not well aligned btw managers and shareholders.
- Special situation - New Frontier Hospital (link)
- 振樺電 (link)
- 癌症精準醫療 (link) (link) (link)
- Invest 50% in Twitter (link)
看過去5-8年ROE是否穩定 配得出現金 (低盈再率+高配息) 產業地位不變 (產品不變+高市占/會變+多角化) 公司要夠大 (常利大於5億元,上市櫃滿2年) 老闆要有誠信 (董監持股至少10%) 僅供參考
留言